-+ 0.00%
-+ 0.00%
-+ 0.00%

Wells Fargo Maintains Overweight on Bio-Techne, Raises Price Target to $76

Benzinga·02/06/2026 16:04:15
Listen to the news
Wells Fargo analyst Brandon Couillard maintains Bio-Techne (NASDAQ:TECH) with a Overweight and raises the price target from $70 to $76.